Atria Investments’s SPDR S&P Pharmaceuticals ETF XPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2015
Q4 | – | Sell |
-22,518
| Closed | -$1.06M | – | 417 |
|
|
2015
Q3 | $1.06M | Buy |
22,518
+1,472
| +7% | +$69.1K | 0.15% | 105 |
|
|
2015
Q2 | $1.31M | Buy |
21,046
+576
| +3% | +$35.9K | 0.15% | 97 |
|
|
2015
Q1 | $1.26M | Sell |
20,470
-2
| -0% | -$123 | 0.14% | 102 |
|
|
2014
Q4 | $1.11M | Buy |
20,472
+2,756
| +16% | +$149K | 0.12% | 145 |
|
|
2014
Q3 | $939K | Buy |
17,716
+2,246
| +15% | +$119K | 0.1% | 179 |
|
|
2014
Q2 | $803K | Sell |
15,470
-4,184
| -21% | -$217K | 0.08% | 208 |
|
|
2014
Q1 | $920K | Buy |
19,654
+2,426
| +14% | +$114K | 0.09% | 185 |
|
|
2013
Q4 | $758K | Buy |
17,228
+2,688
| +18% | +$118K | 0.08% | 219 |
|
|
2013
Q3 | $560K | Sell |
14,540
-278
| -2% | -$10.7K | 0.06% | 261 |
|
|
2013
Q2 | $522K | Buy |
+14,818
| New | +$522K | 0.06% | 175 |
|